文档介绍：Technovation 22 (2002) 353–362
ate/technovation
Myth of market needs and technology seeds as a source of product
innovation — an analysis of pharmaceutical new product
development in an anti-hypertensive product innovation
Makoto Takayama a, b,*, Chihiro Watanabe b
a Yamanouchi Pharmaceutical Co., Ltd, Nishi-magome 1-16-12, Ohta-ku, Tokyo 143-0026, Japan
b Department of Industrial Engineering and Management, Tokyo Institute of Technology, Tokyo, Japan
Received 17 May 2000; received in revised form 30 October 2000; accepted 20 November 2000
Abstract
We generally believe that product innovation frequently occurs by a strong actor who knows the market and technology. For
this reason, the market leader has a stronger position to make an innovative product because of its marketing and technological
competence to know market needs and technology seeds.
This paper studies what kind of product inhibits product innovation. For this purpose, very recent pharmaceutical product changes
are studied. In pharmaceutical products, we have selected an anti-hypertensive product to focus on the mature stage of market needs
and technology seeds for product innovation. In this mature stage, all panies recognize the research target for the existing
innovative product since market needs and technology seeds monly shared among all firms.
By analyzing the characteristics of the